We've found
184,457
clinical trials
We've found
184,457
clinical trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
ArcticLine Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Obstructive Pulmonary Disease Clinical Trial
Updated: 12/31/1969
Mindful Breathing Awareness Through Pursed-Lip Breathing Training
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Transplantation Clinical Trial
Updated: 12/31/1969
OCS™ Lung TOP Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Stroke, Acute Clinical Trial
Updated: 12/31/1969
Volumetric Impedance to Guide Stroke Response
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cancer Clinical Trial
Updated: 12/31/1969
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Cancer Clinical Trial
Updated: 12/31/1969
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Cancer Clinical Trial
Updated: 12/31/1969
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Knee Arthroplasty Clinical Trial
Updated: 12/31/1969
The PATH Study to Promote Physical Activity After Knee Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Follicular Lymphoma (FL) Clinical Trial
Updated: 12/31/1969
Study of ME-401 in Subjects With Follicular Lymphoma After Failure of Two or More Prior Systemic Therapies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Follicular Lymphoma (FL) Clinical Trial
Updated: 12/31/1969
Study of ME-401 in Subjects With Follicular Lymphoma After Failure of Two or More Prior Systemic Therapies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Follicular Lymphoma (FL) Clinical Trial
Updated: 12/31/1969
Study of ME-401 in Subjects With Follicular Lymphoma After Failure of Two or More Prior Systemic Therapies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Follicular Lymphoma (FL) Clinical Trial
Updated: 12/31/1969
Study of ME-401 in Subjects With Follicular Lymphoma After Failure of Two or More Prior Systemic Therapies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Lyme Borreliosis Clinical Trial
Updated: 12/31/1969
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pain Clinical Trial
Updated: 12/31/1969
EXPAREL for Minimally Invasive Supracervical Hysterectomies
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Stress Echocardiography Clinical Trial
Updated: 12/31/1969
Use of Reactivated DEFINITY in Patients Undergoing Stress Echo
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Neurology Clinical Trial
Updated: 12/31/1969
Pharmacodynamics, Safety and Pharmacokinetics of the Oral Administration MNK6106 (L-ornithine Phenylacetate) vs Rifaximin in Participants With Hepatic Cirrhosis and a History of Prior Episodes of Hepatic Encephalopathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Non-small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Cancer (CRC), Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Click here to add this to my saved trials

Hospitalized Patients Clinical Trial
Updated: 12/31/1969
Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trial
Updated: 12/31/1969
Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

High-risk Non-muscle Invasive Bladder Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

High-risk Non-muscle Invasive Bladder Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

High-risk Non-muscle Invasive Bladder Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Pharmacokinetic and Pharmacodynamic Analysis of Ceftaroline in Children and Adolescents With Cystic Fibrosis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Stargardt Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Emixustat in Stargardt Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Rheumatology Clinical Trial
Updated: 12/31/1969
An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Drinking, Alcohol Clinical Trial
Updated: 12/31/1969
A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasms Clinical Trial
Updated: 12/31/1969
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Active Non-segmental Vitiligo Clinical Trial
Updated: 12/31/1969
A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Recurrent Pericarditis Clinical Trial
Updated: 12/31/1969
RHAPSODY Phase 3 Study to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Myeloma Clinical Trial
Updated: 12/31/1969
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Aphasia Clinical Trial
Updated: 12/31/1969
Improving Electronic Written Communication in Aphasia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Patients With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Melanoma Stage IIIB/C Clinical Trial
Updated: 12/31/1969
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Graft-Versus-Host-Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Graft-Versus-Host-Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Early Check: Expanded Screening in Newborns
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hand Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate ASN002 in Subjects With Severe Chronic Hand Eczema
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hand Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate ASN002 in Subjects With Severe Chronic Hand Eczema
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Safety, Pharmacokinetics, and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Adults
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Mechanical Complication of Cardiac Electronic Device Clinical Trial
Updated: 12/31/1969
Multicenter Imaging in Lead Extraction Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cushing Disease Clinical Trial
Updated: 12/31/1969
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Solid Neoplasms Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Surgery Clinical Trial
Updated: 12/31/1969
Endoscopic Suturing (ES) Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy Clinical Trial
Updated: 12/31/1969
A Patient Registry Study for Patients Treated With Voretigene Neparvovec
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy Clinical Trial
Updated: 12/31/1969
A Patient Registry Study for Patients Treated With Voretigene Neparvovec
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cushing's Syndrome Clinical Trial
Updated: 12/31/1969
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cushing's Syndrome Clinical Trial
Updated: 12/31/1969
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus (SLE) Clinical Trial
Updated: 12/31/1969
Omega-3 Replacement With Krill Oil in Disease Management of SLE
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus (SLE) Clinical Trial
Updated: 12/31/1969
Omega-3 Replacement With Krill Oil in Disease Management of SLE
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus (SLE) Clinical Trial
Updated: 12/31/1969
Omega-3 Replacement With Krill Oil in Disease Management of SLE
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus (SLE) Clinical Trial
Updated: 12/31/1969
Omega-3 Replacement With Krill Oil in Disease Management of SLE
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Congenital Hyperinsulinism Clinical Trial
Updated: 12/31/1969
Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Congenital Hyperinsulinism Clinical Trial
Updated: 12/31/1969
Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastric, or Gastroesophageal Junction Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastric, or Gastroesophageal Junction Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
